[Federal Register Volume 62, Number 115 (Monday, June 16, 1997)]
[Notices]
[Page 32618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of public advisory 
committees of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committees: Joint meeting of the Nonprescription Drugs 
Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory 
Committee.
    General Function of the Committees: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on July 16, 1997, 8:30 a.m. 
to 5 p.m.
    Location: Holiday Inn, Versailles Ballrooms I and II, 8120 
Wisconsin Ave., Bethesda, MD.
    Contact Person: Andrea G. Neal or Tracy Riley, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), codes 12541 and 12534. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will hear presentations and discuss data 
submitted regarding the over-the-counter status of new drug application 
(NDA) 20-834, Rogaine (minoxidil 5% topical solution), The 
Pharmacia & Upjohn Co. for use as a hair growth stimulant by men with 
androgenetic alopecia.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by July 3, 1997. 
Oral presentations from the public will be scheduled between 
approximately 8:30 a.m. to 9:30 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before July 3, 1997, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).


    Dated: June 9, 1997.
 Michael A. Friedman,
 Deputy Commissioner for Operations.
[FR Doc. 97-15632 Filed 6-13-97; 8:45 am]
BILLING CODE 4160-01-F